Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Gene Ther ; 22(2): 138-45, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25427613

RESUMO

We evaluated the effect of AAV2- and 17-AAG (17-N-allylamino-17-demethoxygeldanamycin)-mediated upregulation of Hsp70 expression on the survival of retinal ganglion cells (RGCs) injured by optic nerve crush (ONC). AAV2-Hsp70 expression in the retina was primarily observed in the ganglion cell layer. Approximately 75% of all transfected cells were RGCs. RGC survival in AAV2-Hsp70-injected animals was increased by an average of 110% 2 weeks after the axonal injury compared with the control. The increase in cell numbers was not even across the retinas with a maximum effect of approximately 306% observed in the inferior quadrant. 17-AAG-mediated induction of Hsp70 expression has been associated with cell protection in various models of neurodegenerative diseases. We show here that a single intravitreal injection of 17-AAG (0.2 ug ul(-1)) results in an increased survival of ONC-injured RGCs by approximately 49% compared with the vehicle-treated animals. Expression of Hsp70 in retinas of 17-AAG-treated animals was upregulated approximately by twofold compared with control animals. Our data support the idea that the upregulation of Hsp70 has a beneficial effect on the survival of injured RGCs, and the induction of this protein could be viewed as a potential neuroprotective strategy for optic neuropathies.


Assuntos
Benzoquinonas/farmacologia , Dependovirus/genética , Proteínas de Choque Térmico HSP70/genética , Lactamas Macrocíclicas/farmacologia , Traumatismos do Nervo Óptico/terapia , Células Ganglionares da Retina/fisiologia , Animais , Axônios/patologia , Sobrevivência Celular , Terapia Combinada , Terapia Genética , Proteínas de Choque Térmico HSP70/metabolismo , Humanos , Camundongos Endogâmicos C57BL , Compressão Nervosa , Regeneração Nervosa , Retina/metabolismo , Retina/patologia , Ativação Transcricional , Transdução Genética
2.
Gene Ther ; 16(1): 17-25, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18701913

RESUMO

We investigated the neuroprotective effect of thioredoxin 1 (Trx1) and thioredoxin 2 (Trx2) which play critical roles in the regulation of oxidative stress on retinal ganglion cells (RGCs) in a rat glaucoma model. Expression of Trx1 and Trx2 and Trx-interacting protein (Txnip) was observed in the RGC layer (GCL), nerve fiber layer and inner nuclear layer. Txnip-, Trx1- and Trx2-expressing cells in the GCL were primarily colocalized with RGCs. The increased Txnip protein level was observed 2 and 5 weeks after glaucoma induction. Trx1 level decreased 2 weeks after glaucoma induction and more prominently after 5 weeks. No change in Trx2 levels was detected. The effects of Trx1 and Trx2 overexpression on RGC survival were evaluated 5 weeks after glaucoma induction. In nontransfected and EGFP-transfected (used as a negative control) retinas, RGC loss was approximately 27% compared with control. The loss of RGCs in Trx1- and Trx2- transfected retinas was approximately 15 and 17%, respectively. Thus, Trx1 and Trx2 preserved 45 and 37% of cells, respectively that were destined to die in glaucomatous retinas. The results of this study provide evidence for the involvement of oxidative stress in RGC degeneration in experimental glaucoma and point to potential strategies to reduce its impact.


Assuntos
Terapia Genética/métodos , Glaucoma/terapia , Células Ganglionares da Retina/metabolismo , Tiorredoxinas/genética , Animais , Contagem de Células , Eletroporação/métodos , Expressão Gênica , Glaucoma/metabolismo , Glaucoma/patologia , Imuno-Histoquímica , Modelos Animais , Degeneração Neural , Estresse Oxidativo , Ratos , Ratos Wistar , Células Ganglionares da Retina/patologia , Tiorredoxinas/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA